435 related articles for article (PubMed ID: 20113167)
1. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers.
Jia L; Shen J; Zhang D; Duan C; Liu G; Zheng D; Tian X; Liu Y; Zhang Q
Int J Biol Macromol; 2012 Apr; 50(3):523-9. PubMed ID: 22301003
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characteristics of monostearin nanostructured lipid carriers.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Int J Pharm; 2006 May; 314(1):83-9. PubMed ID: 16563671
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
[TBL] [Abstract][Full Text] [Related]
6. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies on the oridonin-loaded nanostructured lipid carriers.
Zheng D; Dai W; Zhang D; Duan C; Jia L; Liu Y; Zhang Q
Drug Deliv; 2012 Aug; 19(6):286-91. PubMed ID: 22928767
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and in vitro characterization of apigemin-loaded nanostructured lipid carriers].
Zhai YJ; Guo CY; Hou JN; Zhang WD; Zhai GX
Zhong Yao Cai; 2011 Jun; 34(6):962-5. PubMed ID: 22017012
[TBL] [Abstract][Full Text] [Related]
11. Design and characterization of Amoitone B-loaded nanostructured lipid carriers for controlled drug release.
Luan J; Zhang D; Hao L; Li C; Qi L; Guo H; Liu X; Zhang Q
Drug Deliv; 2013 Nov; 20(8):324-30. PubMed ID: 24032657
[TBL] [Abstract][Full Text] [Related]
12. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
[TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers as a delivery system of biochanin A.
Wang Q; Cheng H; Zhou K; Wang L; Dong S; Wang D; Chen W
Drug Deliv; 2013 Nov; 20(8):331-7. PubMed ID: 24111887
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers.
Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G
Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
Teeranachaideekul V; Müller RH; Junyaprasert VB
Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
[TBL] [Abstract][Full Text] [Related]
16. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
Fang JY; Fang CL; Liu CH; Su YH
Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of modified lipid nanoparticles for doxorubicin controlled release.
Ying XY; Du YZ; Chen WW; Yuan H; Hu FQ
Pharmazie; 2008 Dec; 63(12):878-82. PubMed ID: 19177903
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of galactosylated bovine serum albumin nanoparticles for liver-targeted delivery of oridonin.
Li C; Zhang D; Guo H; Hao L; Zheng D; Liu G; Shen J; Tian X; Zhang Q
Int J Pharm; 2013 May; 448(1):79-86. PubMed ID: 23518367
[TBL] [Abstract][Full Text] [Related]
19. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
Castelli F; Puglia C; Sarpietro MG; Rizza L; Bonina F
Int J Pharm; 2005 Nov; 304(1-2):231-8. PubMed ID: 16188405
[TBL] [Abstract][Full Text] [Related]
20. Lipid nanoparticles with different oil/fatty ester ratios as carriers of buprenorphine and its prodrugs for injection.
Wang JJ; Liu KS; Sung KC; Tsai CY; Fang JY
Eur J Pharm Sci; 2009 Sep; 38(2):138-46. PubMed ID: 19591929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
